Literature DB >> 12450730

Familial nasopharyngeal carcinoma.

Yi-Xin Zeng1, Wei-Hua Jia.   

Abstract

Nasopharyngeal carcinoma (NPC) has a striking geographical and ethnical distribution. It occurs with high frequency in southern China and Southeast Asia. Family clustering was also observed in NPC and a typical family with 15 NPC cases was introduced in this paper. Epidemiological and genetic studies have been carried out in the previous decades and vast information was accumulated for familiar NPC, in terms of risk factors, inheritance mode, and involvement of gene polymorphisms. The major findings in this field were summarized. Furthermore, future directions leading to understanding the genetic mechanism of the familial form of NPC was also discussed. Copyright 2002 Elsevier Science Ltd.

Entities:  

Mesh:

Year:  2002        PMID: 12450730     DOI: 10.1016/s1044579x02000871

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  23 in total

1.  Nasopharyngeal carcinoma in a south European population: epidemiological data and clinical aspects in Portugal.

Authors:  Breda Eduardo; Catarino Raquel; Medeiros Rui
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-08       Impact factor: 2.503

2.  Quality of life of nasopharyngeal carcinoma survivors in Mainland China.

Authors:  Yong Wu; Wei-Han Hu; Yun-Fei Xia; Jun Ma; Meng-Zhong Liu; Nian-Ji Cui
Journal:  Qual Life Res       Date:  2006-10-11       Impact factor: 4.147

3.  Quantification of familial risk of nasopharyngeal carcinoma in a high-incidence area.

Authors:  Zhiwei Liu; Ellen T Chang; Qing Liu; Yonglin Cai; Zhe Zhang; Guomin Chen; Qi-Hong Huang; Shang-Hang Xie; Su-Mei Cao; Jian-Yong Shao; Wei-Hua Jia; Yuming Zheng; Jian Liao; Yufeng Chen; Longde Lin; Liming Liang; Ingemar Ernberg; Thomas L Vaughan; Hans-Olov Adami; Guangwu Huang; Yi Zeng; Yi-Xin Zeng; Weimin Ye
Journal:  Cancer       Date:  2017-02-27       Impact factor: 6.860

4.  CYP2E1 Rsa I/Pst I polymorphism contributes to oral cancer susceptibility: a meta-analysis.

Authors:  Yuming Niu; Yuanyuan Hu; Mingyue Wu; Fei Jiang; Ming Shen; Chunbo Tang; Ning Chen
Journal:  Mol Biol Rep       Date:  2011-05-07       Impact factor: 2.316

5.  Comparison of narrow-band imaging and conventional nasopharyngoscopy for the screening of unaffected members of families with nasopharyngeal carcinoma.

Authors:  Ching-Yin Ho; Kee-Tak Chan; Pen-Yuan Chu
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-01-23       Impact factor: 2.503

6.  Aberrant activation of hedgehog pathway in nasopharyngeal carcinoma.

Authors:  Yongjian Yue; Weide Zhong; Genwang Pei; Baiyu Xiao; Guoping Zhang; Funeng Jiang; Jinglin Zhang; Changhua Chen; Peizhou Yang; Hua Dang; Hong Chang
Journal:  Clin Exp Med       Date:  2012-07-20       Impact factor: 3.984

7.  Secular trends of nasopharyngeal carcinoma incidence in Singapore, Hong Kong and Los Angeles Chinese populations, 1973-1997.

Authors:  Juhua Luo; Kee Seng Chia; Sin Eng Chia; Marie Reilly; Chuen Seng Tan; Weimin Ye
Journal:  Eur J Epidemiol       Date:  2007-06-27       Impact factor: 8.082

8.  Familial nasopharyngeal carcinoma in Hong Kong: epidemiology and implication in screening.

Authors:  Wai Tong Ng; Cheuk Wai Choi; Michael C H Lee; Siu Hong Chan; Tsz Kok Yau; Anne W M Lee
Journal:  Fam Cancer       Date:  2008-08-26       Impact factor: 2.375

9.  A case-control and a family-based association study revealing an association between CYP2E1 polymorphisms and nasopharyngeal carcinoma risk in Cantonese.

Authors:  Wei-Hua Jia; Qing-Hua Pan; Hai-De Qin; Ya-Fei Xu; Guo-Ping Shen; Lina Chen; Li-Zhen Chen; Qi-Sheng Feng; Ming-Huang Hong; Yi-Xin Zeng; Yin Yao Shugart
Journal:  Carcinogenesis       Date:  2009-12       Impact factor: 4.944

10.  Different subsets of tumor infiltrating lymphocytes correlate with NPC progression in different ways.

Authors:  Yi-Lan Zhang; Jiang Li; Hao-Yuan Mo; Fang Qiu; Li-Min Zheng; Chao-Nan Qian; Yi-Xin Zeng
Journal:  Mol Cancer       Date:  2010-01-10       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.